RL
ADMA icon

Ruffer LLP’s ADMA Biologics ADMA Stock Holding History

Ruffer LLP’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.54M Buy
+422,958
New +$3.86M 0.13% 119

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Ruffer LLP's ADMA Position: Q2 2026 in Review

Ruffer LLP opened a new position in ADMA Biologics (ADMA) in Q2 2026: 422,958 shares worth $3.54M. The stake represents 0.13% of the portfolio and ranks #119 among its holdings.

79 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Ruffer LLP held 422,958 shares of ADMA Biologics worth $3.54M as of Q2 2026.
  • ADMA Biologics was a new Ruffer LLP position in Q2 2026.
  • ADMA Biologics made up 0.13% of Ruffer LLP's portfolio in Q2 2026, its #119 holding.
  • 79 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Ruffer LLP's 13F filing for Q2 2026, filed 30 Jul 2026.